Global Genome Sequencing Market 2019:Industry Analysis by Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies.& Others

The genome sequencing market research report is conceivable and verifiable research report secured to give genuine information. The report undoubtedly maintains the high level of accuracy. Assumptions included in this genome sequencing report are made through considering experts’ opinions and then the results are cross-checked against the autonomous sources, before being approved through an iterative interview process with specialists and partners. The report analyzes different viewpoints of the market with the assistance of Porter’s five powers examination. It helps to cultivate vital activities by understanding the center regions of prominent organizations in the business.

Ask For Complimentary Sample PDF| Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-sequencing-market

By referring to this genome sequencing market report, clients can get a clear idea about mergers and acquisitions viably by comprehension and recognition of key players. It concentrates on the product type and regions that witness the fastest growth in the market. The report gives a point by point investigation of the changing focused scene that keeps the readers/customers in front of the contenders. It likewise gives an inside-out perspective on the various components driving or controlling the development of the worldwide market. It helps with settling on educated business choices by having careful experiences into the worldwide market.

Market Analysis: 

Global genome sequencing market is expected to rise to an estimated value of USD 47.97 billion by 2026 registering a substantial CAGR of 13.95% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising government spending, rise in the applications of genomics and the declining sequencing costs.

Key Market Competitors: 

Few of the major market competitors currently working in the genome sequencing market are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., amongst others.

Market Definition:

Genome sequencing is the process of mapping and sequencing of the unique DNA of a person. Genome represents the entire blueprint of a person’s human body. Genome sequencing helps to identify any significant variations in the genes, which are a bundle of DNA, in a person’s body which can cause a disease or increase the likelihood of a disease. It can be used to find out genome information about almost anything including bacteria, plants, and animals. It has its wide applicability in the medicine and pharma industry.

 Market Drivers

Increased funding and initiative by the government to promote genome sequencing and its varied applicability in numerous projects accelerates the growth of this market

Reduction in the costs of genome sequencing further boosts the growth of this market

Growing applicability of genomes in various areas including diagnosis, animal research, agriculture, drug discovery, food and beverages etc.

With changing environment of operations and advancements in technology, several new opportunities have been created thereby leading to the entry of new players and start-ups that would foster the growth of this market

Market Restraints

Expensive and high cost of genome equipments

Lack of skilled professionals

Major Topics Covered in this Report:

Study Coverage

Executive Summary

Market Size by Manufacturers

Market Size by Type

Market Size by Application

Manufacturers Profiles

Production Forecasts

Consumption Forecast

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-genome-sequencing-market

Segmentation: 

By Product and Services

Consumables

Systems & Software

Services

By Technology

Sequencing

Microarray

Nucleic Acid Extraction & Purification

Other Technologies

By Applications

Diagnostics

Drug Discovery & Development

Precision Medicine

Agriculture & Animal Research

Other Applications

By End User

Pediatric

Research Centers

Academic & Government Institutes

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Other End Users

By Geography

North America

South America

Europe

Asia-Pacific

Middle East and Africa

Key Developments in the Market:

In November 2018, Illumina Inc., the genome sequencing giants acquires Pacific Biosciences, a developer and manufacturer of gene sequencing. With this acquisition it would combine its own short genome/DNA sequencing with the long-read sequencing technology of Pacific Biosciences in order to maintain its dominant position in the genomes market, and continue to remain the market leader. With this, it would be able to enter into a new market especially in the areas of rare and undiagnosed diseases, thereby expanding its customer base and providing innovative solutions and services to its clients.

In June 2017, GATC Biotech AG, a leading company in genome sequencing was acquired by Eurofins, the global pioneering leader in bio-analytical testing including DNA, genome testing. With this acquisition Eurofins would expand its product portfolio and better serve its present and future clients by strengthening its genomics and genomic sequencing testing by acquiring the market leader in genomes.

Competitive Analysis: Global Genome Sequencing Market

Global genome sequencing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genome sequencing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

Current and future of global genome sequencing market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Inquiry For Customize Report With Discount at : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genome-sequencing-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research 11374 Articles
Hi, I am Ravi Kumar, a Blogger, Freelancer, SEO Consultant, an Internet Marketer, I am a research analyst who loves to evaluate data relating to Manufacturing industry, Management of companies and enterprises, Finance and insurance, Wholesale trade, Management, scientific, and technical consulting services

Leave a Reply

Your email address will not be published.


*